49342 First FASN inhibitor ASC40 to treat acne vulgaris patients: final results form a Phase 2 trial
| Autor: | Xiang, Leihong, Chen, Rixin, Wu, Liming, Xu, Ai'e, He, Li, Wang, Jinyan, Lu, Yan, Xiao, Rong, Liu, Lunfei, Feng, Yanyan, Wu, Jinzi J. |
|---|---|
| Zdroj: | In Journal of the American Academy of Dermatology September 2024 91(3) Supplement:AB217-AB217 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect